HomeNewsBusinessReal EstateNever trust builder agreement, says homebuyer who won Rs 1.19-crore order from real estate developer

Never trust builder agreement, says homebuyer who won Rs 1.19-crore order from real estate developer

Oman-based Sanjay Rastogi won a hard-fought legal victory at the National Consumer Disputes Redressal Commission against BPTP. Such triumphs by homebuyers are rare against builders. He explains the case and how he managed a legal victory.

July 10, 2020 / 17:10 IST
Story continues below Advertisement

On June 18, a consumer protection body directed a leading real estate company to refund Rs 1.19 crore to a homebuyer. In its first virtual order amid the coronavirus lockdown, the National Consumer Disputes Redressal Commission’s (NCDRC) also asked the builder, BPTP, to pay Rs 50,000 as cost of litigation as well as an interest of 10 percent a year to Oman-based Sanjay Rastogi.

Rastogi had launched a litany of complaints against BPTP, a 13-year-old Delhi-NCR developer that owns around 30 projects. He accused the company of unfair trade practices such as deficiency in service, delay in construction, onerous and one-sided terms and conditions as well as escalating the total price from Rs 1.26 crore to around Rs 1.45 crore.

Story continues below Advertisement

Rastogi’s victory is significant considering the growing number of cases filed by homebuyers who have been given the short shrift by unscrupulous builders.

Delays, Price Hikes

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show